New study suggests hearing loss may be early indicator of Parkinson's

New study suggests hearing loss may be early indicator of Parkinson's

There may be a link between hearing impairment and an increased risk of developing Parkinson's according to research led by Lancaster University.

Parkinson's study testing therapy for patients with GBA1 mutations

The first patient in a Phase 2 clinical study testing BIA 28-6156 — a small molecule in the pipeline at Bial for treating Parkinson’s disease in people with mutations in the GBA1 gene — has completed the full dose regimen, the company announced. The goal of the study, called ACTIVATE (NCT05819359), is to check how well BIA 28-6156 works against a placebo in delaying the clinical progression of motor symptoms in people with GBA1 mutations — who a…

The journalist was diagnosed with this disease and will now travel to Europe to be evaluated for a vaccine that is in Phase 2 of development.

Emiliano Pinsón, a 52-year-old sports journalist, told a hopeful news story about his fight against Parkinson, a disease that he was detected in June 2022. In a video on social networks, he announced that he would participate in an experimental protocol in Spain to test a specific vaccine. “I was given the OK to do a test in Osasuna, in a hospital with an experimental protocol. It has to do with a vaccine for the exact pathology that I have, whi…